REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 151 filers reported holding REVOLUTION MEDICINES INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $413,000 | +81.9% | 14,899 | +75.4% | 0.00% | – |
| Q2 2023 | $227,000 | +106.4% | 8,495 | +66.5% | 0.00% | – |
| Q1 2023 | $110,000 | -53.0% | 5,103 | -48.0% | 0.00% | – |
| Q4 2022 | $234,000 | +963.6% | 9,818 | +786.1% | 0.00% | – |
| Q3 2022 | $22,000 | +100.0% | 1,108 | +99.6% | 0.00% | – |
| Q2 2022 | $11,000 | -88.8% | 555 | -85.6% | 0.00% | – |
| Q1 2022 | $98,000 | +16.7% | 3,850 | +16.0% | 0.00% | – |
| Q4 2021 | $84,000 | +75.0% | 3,320 | +89.2% | 0.00% | – |
| Q3 2021 | $48,000 | -65.0% | 1,755 | -41.4% | 0.00% | – |
| Q1 2021 | $137,000 | +585.0% | 2,994 | +503.6% | 0.00% | – |
| Q4 2020 | $20,000 | +1900.0% | 496 | +1553.3% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 30 | +20.0% | 0.00% | – |
| Q2 2020 | $1,000 | -93.3% | 25 | -96.5% | 0.00% | – |
| Q1 2020 | $15,000 | – | 708 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |